A Twelve Week Safety and Efficacy Study in Rosacea

NCT01784133 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

240

Enrollment

INDUSTRY

Sponsor class

Conditions

Papulopustular Rosacea

Interventions

DRUG: omiganan
DRUG: placebo

Sponsor

Maruho Co., Ltd.